{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T07:16:14Z","timestamp":1781594174014,"version":"3.54.5"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,16]],"date-time":"2017-08-16T00:00:00Z","timestamp":1502841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,8,16]],"date-time":"2017-08-16T00:00:00Z","timestamp":1502841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["15653129"],"award-info":[{"award-number":["15653129"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["15K09977"],"award-info":[{"award-number":["15K09977"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["16K19790"],"award-info":[{"award-number":["16K19790"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["16K19789"],"award-info":[{"award-number":["16K19789"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["16768966"],"award-info":[{"award-number":["16768966"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003382","name":"Core Research for Evolutional Science and Technology","doi-asserted-by":"publisher","award":["JPMJCR1652"],"award-info":[{"award-number":["JPMJCR1652"]}],"id":[{"id":"10.13039\/501100003382","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13550-017-0313-0","type":"journal-article","created":{"date-parts":[[2017,8,16]],"date-time":"2017-08-16T12:23:40Z","timestamp":1502886220000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["A human PET study of [11C]HMS011, a potential radioligand for AMPA receptors"],"prefix":"10.1186","volume":"7","author":[{"given":"Keisuke","family":"Takahata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7927-9483","authenticated-orcid":false,"given":"Yasuyuki","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chie","family":"Seki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Tokunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Ichise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maiko","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soichiro","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Moriguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhei","family":"Takado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumitoshi","family":"Niwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironobu","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohisa","family":"Nagashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Ikoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Rong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Suhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,16]]},"reference":[{"key":"313_CR1","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.neuropharm.2008.08.023","volume":"56","author":"DE Jane","year":"2009","unstructured":"Jane DE, Lodge D, Collingridge GL. Kainate receptors: pharmacology, function and therapeutic potential. Neuropharmacology. 2009;56:90\u2013113.","journal-title":"Neuropharmacology"},{"key":"313_CR2","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/BF00231156","volume":"83","author":"GG Hwa","year":"1991","unstructured":"Hwa GG, Avoli M, Oliver A, Villemure JG. Bicuculline-induced epileptogenesis in the human neocortex maintained in vitro. Exp Brain Res. 1991;83:329\u201339.","journal-title":"Exp Brain Res"},{"key":"313_CR3","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1523\/JNEUROSCI.16-13-04069.1996","volume":"16","author":"SG Carriedo","year":"1996","unstructured":"Carriedo SG, Yin HZ, Weiss JH. Motor neurons are selectively vulnerable to AMPA\/kainate receptor-mediated injury in vitro. J Neurosci. 1996;16:4069\u201379.","journal-title":"J Neurosci"},{"key":"313_CR4","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/j.bcp.2005.12.022","volume":"71","author":"A Alt","year":"2006","unstructured":"Alt A, Nisenbaum ES, Bleakman D, Witkin JM. A role for AMPA receptors in mood disorders. Biochem Pharmacol. 2006;71:1273\u201388.","journal-title":"Biochem Pharmacol"},{"key":"313_CR5","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/syn.10106","volume":"45","author":"JT Noga","year":"2002","unstructured":"Noga JT, Wang H. Further postmortem autoradiographic studies of AMPA receptor binding in schizophrenia. Synapse. 2002;45:250\u20138.","journal-title":"Synapse"},{"key":"313_CR6","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/0920-1211(93)90054-B","volume":"15","author":"S Yamaguchi","year":"1993","unstructured":"Yamaguchi S, Donevan SD, Rogawski MA. Anticonvulsant activity of AMPA\/kainate antagonists: comparison of GYKI 52466 and NBQX in maximal electroshock and chemoconvulsant seizure models. Epilepsy Res. 1993;15:179\u201384.","journal-title":"Epilepsy Res"},{"key":"313_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.nurt.2006.11.010","volume":"4","author":"BS Meldrum","year":"2007","unstructured":"Meldrum BS, Rogawski MA. Molecular targets for antiepileptic drug development. Neurotherapeutics. 2007;4:18\u201361.","journal-title":"Neurotherapeutics"},{"key":"313_CR8","doi-asserted-by":"publisher","first-page":"10584","DOI":"10.1021\/jm301268u","volume":"55","author":"S Hibi","year":"2012","unstructured":"Hibi S, Ueno K, Nagato S, Kawano K, Ito K, Norimine Y, et al. Discovery of 2-(2-Oxo-1-phenyl-5-pyridin-2-yl-1,2-dihydropyridin-3-yl)benzonitrile (Perampanel): a novel, noncompetitive \u03b1-amino-3-hydroxy-5-methyl-4-isoxazolepropanoic acid (AMPA) receptor antagonist. J Med Chem. 2012;55:10584\u2013600.","journal-title":"J Med Chem"},{"key":"313_CR9","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s40263-013-0091-9","volume":"27","author":"WWQ Hsu","year":"2013","unstructured":"Hsu WWQ, Sing CW, He Y, Worsley AJ, Wong ICK, Chan EW. Systematic review and meta-analysis of the efficacy and safety of perampanel in the treatment of partial-onset epilepsy. CNS Drugs. 2013;27:817\u201327.","journal-title":"CNS Drugs"},{"key":"313_CR10","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/j.1528-1167.2012.03648.x","volume":"54","author":"GL Krauss","year":"2013","unstructured":"Krauss GL, Perucca E, Ben-Menachem E, Kwan P, Shih JJ, Squillacote D, et al. Perampanel, a selective, noncompetitive \u03b1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, as adjunctive therapy for refractory partial-onset seizures: interim results from phase III, extension study 307. Epilepsia. 2013;54:126\u201334.","journal-title":"Epilepsia"},{"key":"313_CR11","doi-asserted-by":"publisher","first-page":"8444","DOI":"10.1021\/acs.jmedchem.5b00712","volume":"58","author":"N Oi","year":"2015","unstructured":"Oi N, Tokunaga M, Suzuki M, Nagai Y, Nakatani Y, Yamamoto N, et al. Development of novel PET probes for central 2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid receptors. J Med Chem. 2015;58:8444\u201362.","journal-title":"J Med Chem"},{"key":"313_CR12","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/0006-8993(84)91025-4","volume":"309","author":"TC Rainbow","year":"1984","unstructured":"Rainbow TC, Wieczorek CM, Halpain S. Quantitative autoradiography of binding sites for [3H] AMPA, a structural analogue of glutamic acid. Brain Res. 1984;309:173\u20137.","journal-title":"Brain Res"},{"key":"313_CR13","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1109\/TAC.1974.1100705","volume":"19","author":"H Akaike","year":"1974","unstructured":"Akaike H. A new look at the statistical model identification. IEEE Trans Automat Contr. 1974;19:716\u201323.","journal-title":"IEEE Trans Automat Contr"},{"key":"313_CR14","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/(SICI)1098-2396(19991215)34:4<290::AID-SYN5>3.0.CO;2-B","volume":"34","author":"M Fujita","year":"1999","unstructured":"Fujita M, Seibyl JP, Verhoeff NP, Ichise M, Baldwin RM, Zoghbi SS, et al. Kinetic and equilibrium analyses of [123I]epidepride binding to striatal and extrastriatal dopamine D2 receptors. Synapse. 1999;34:290\u2013304.","journal-title":"Synapse"},{"key":"313_CR15","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/jcbfm.1986.30","volume":"6","author":"RA Hawkins","year":"1986","unstructured":"Hawkins RA, Phelps ME, Huang S-C. Effects of temporal sampling, glucose metabolic rates, and disruptions of the blood-brain barrier on the FDG model with and without a vascular compartment: studies in human brain tumors with PET. J Cereb Blood Flow Metab. 1986;6:170\u201383.","journal-title":"J Cereb Blood Flow Metab"},{"key":"313_CR16","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/jcbfm.1990.127","volume":"10","author":"J Logan","year":"1990","unstructured":"Logan J, Fowler JS, Volkow ND, Wolf AP, Dewey SL, Schlyer DJ, et al. Graphical analysis of reversible radioligand binding from time\u2014activity measurements applied to [N-11C-methyl]-(\u2212)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab. 1990;10:740\u20137.","journal-title":"J Cereb Blood Flow Metab"},{"key":"313_CR17","first-page":"1902","volume":"40","author":"M Ichise","year":"1999","unstructured":"Ichise M, Fujita M, Seibyl JP, Verhoeff NP, Baldwin RM, Zoghbi SS, et al. Graphical analysis and simplified quantification of striatal and extrastriatal dopamine D2 receptor binding with [123I]epidepride SPECT. J Nucl Med. 1999;40:1902\u201312.","journal-title":"J Nucl Med"},{"key":"313_CR18","first-page":"513","volume":"37","author":"M Ichise","year":"1996","unstructured":"Ichise M, Ballinger JR, Golan H, Vines D, Luong A, Tsai S, et al. Noninvasive quantification of dopamine D2 receptors with iodine-123-IBF SPECT. J Nucl Med. 1996;37:513\u201320.","journal-title":"J Nucl Med"},{"key":"313_CR19","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/0169-328X(93)90058-W","volume":"20","author":"DR Weaver","year":"1993","unstructured":"Weaver DR. A2a adenosine receptor gene expression in developing rat brain. Brain Res Mol Brain Res. 1993;20:313\u201327.","journal-title":"Brain Res Mol Brain Res"},{"key":"313_CR20","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1046\/j.1471-4159.1996.66010362.x","volume":"66","author":"RA Peterfreund","year":"1996","unstructured":"Peterfreund RA, MacCollin M, Gusella J, Fink JS. Characterization and expression of the human A2a adenosine receptor gene. J Neurochem. 1996;66:362\u20138.","journal-title":"J Neurochem"}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-017-0313-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13550-017-0313-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-017-0313-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T18:03:05Z","timestamp":1589652185000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejnmmires.springeropen.com\/articles\/10.1186\/s13550-017-0313-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,16]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["313"],"URL":"https:\/\/doi.org\/10.1186\/s13550-017-0313-0","relation":{},"ISSN":["2191-219X"],"issn-type":[{"value":"2191-219X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,16]]},"assertion":[{"value":"26 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Radiation Drug Safety Committee and the Institutional Review Board of National Institute of Radiological Sciences of Japan (#15-010). All procedures performed in the preset study involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the ethical standards laid down in the principles of the 1964 Declaration of Helsinki and its later amendment or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"TS has received grant support from Eisai Co., Ltd. All other authors declare that they have no conflict of interest. The precursor and reference standard of [<sup>11<\/sup>C]HMS011 for the present study were provided by Eisai Co., Ltd.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"63"}}